Morning Market Losers By: Benzinga via Benzinga May 14, 2014 at 10:04 AM EDT Enzymotec (NASDAQ: ENZY) declined 29.86% to $14.19 after the company reported Q1 earnings of $0.24 per share on revenue of $17.90 ... Read More >> Related Stocks: Fossil Group Hydrogenics Corp Take-Two Interactive USA Compression Partners LP